Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP – Get Free Report) saw a significant growth in short interest during the month of July. As of July 31st, there was short interest totaling 24,355 shares, a growth of 465.6% from the July 15th total of 4,306 shares. Based on an average trading volume of 9,824 shares, the days-to-cover ratio is presently 2.5 days. Currently, 2.4% of the company’s shares are short sold.
Virtus LifeSci Biotech Products ETF Price Performance
Shares of Virtus LifeSci Biotech Products ETF stock traded down $0.83 during midday trading on Thursday, reaching $101.09. The company had a trading volume of 7,685 shares, compared to its average volume of 8,265. The stock has a fifty day moving average price of $95.07 and a 200 day moving average price of $87.97. Virtus LifeSci Biotech Products ETF has a fifty-two week low of $66.22 and a fifty-two week high of $105.21.
Institutional Inflows and Outflows
An institutional investor recently bought a new stake in Virtus LifeSci Biotech Products ETF stock. Comprehensive Financial Planning Inc. PA acquired a new position in shares of Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,971 shares of the company’s stock, valued at approximately $557,000. Comprehensive Financial Planning Inc. PA owned 1.27% of Virtus LifeSci Biotech Products ETF as of its most recent SEC filing.
About Virtus LifeSci Biotech Products ETF
The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.
See Also
- Five stocks we like better than Virtus LifeSci Biotech Products ETF
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Virtus LifeSci Biotech Products ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virtus LifeSci Biotech Products ETF and related companies with MarketBeat.com's FREE daily email newsletter.
